Nettsider med emneord «Biostatistics»

We develop methods to integrate multi-omics and other data, e.g. clinical data or drug characteristics, for predicting a patient's prognosis or treatment response. In this way we contribute to the development of novel cancer treatments.

Dr. Harald Binder, Professor, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Johannes Gutenberg University Mainz, Germany, will present the lecture: 

"Two uses of stagewise regression: from landmarking in cancer patients to deep learning for SNPs".